Arcadia Biosciences (RKDA) is scheduled to report Q3 earnings on November 6, 2026.
Arcadia Biosciences has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Arcadia Biosciences has averaged an EPS surprise of 2.6% and a revenue surprise of 0.28%.
Earnings Date
Aug 13
EPS
$-2.090
Quarterly Revenue
$1.44M
Annual Revenue
$4.75M
as of Jun 30
Analyze the earnings history of Arcadia Biosciences using advanced sorting and filters.
The chart below shows Arcadia Biosciences's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Arcadia Biosciences's reported revenue compared to analyst estimates over recent quarters.
Arcadia Biosciences (RKDA) is scheduled to report earnings on November 6, 2026. The last reported earnings were for reported on August 13, 2026 for Q2.
The Actual EPS was $-2.09, which missed the estimate of $0.
The Actual Revenue was $1.44M, which beat the estimate of $0.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | May 14, 2026 | $-2.11 | $-0.80 | -163.8 % |
| Q4 | Mar 26, 2026 | $-0.97 | $-0.66 | -47.0 % |
| Q3 | Nov 7, 2025 | $0.63 | $-0.54 | 216.7 % |
| Q1 | May 8, 2025 | $1.90 | $-0.37 | 613.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 14, 2026 | $1.10M | $1.60M | -31.3 % |
| Q4 | Mar 26, 2026 | $901.00K | $1.40M | -35.6 % |
| Q3 | Nov 7, 2025 | $1.30M | $1.90M | -31.5 % |
| Q2 | Aug 14, 2025 | $1.46M | $1.60M | -9.06 % |